Drugs Made In America Acquisition DMAA
NASDAQ DMAA
$10.75 +0.02 (+0.23%)
As of: Aug 21, 2026 · 2:31 PM EDT

Drugs Made In America Acquisition (DMAA) Income from Continuing Operations (2025)

Drugs Made In America Acquisition's (DMAA) quarterly Income from Continuing Operations came in at 212958.0 in Q4 2025, down 90.25% on a QoQ basis from 2184563.0 in Q3 2025.

Drugs Made In America Acquisition (DMAA) Income from Continuing Operations (2025) Analysis & Trends

Drugs Made In America Acquisition (DMAA) has 1 years of Income from Continuing Operations data on file, last reported at 212958.0 in Q4 2025.

  • Quarterly Income from Continuing Operations changed N/A year-over-year to 212958.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 5940643.0 (changed N/A YoY) and the FY2025 annual result came in at 5940643.0, up 2222.83% from the prior year.
  • Income from Continuing Operations eased to 212958.0 in Q4 2025, from 2184563.0 in the prior quarter.
  • In the past five years, Income from Continuing Operations ranged from a high of 2288579.0 in Q2 2025 to a low of 212958.0 in Q4 2025.
Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Income (Continuing) (Qtr)
1 Oxley Bridge Acquisition 585.76 Mn 585.76 Mn - 2.11 Mn
2 Launch Two Acquisition 557.86 Mn 557.86 Mn - 1.95 Mn
3 Drugs Made In America Acquisition 507.00 Mn 507.00 Mn - 4.40 Mn
4 Cantor Equity Partners IV 468.00 Mn 468.00 Mn - 3.92 Mn
5 GP-Act III Acquisition 401.06 Mn 401.06 Mn - 290,121.00
6 Aldel Financial 397.49 Mn 397.49 Mn - 2.11 Mn
7 Republic Digital Acquisition 389.25 Mn 388.51 Mn - 2.65 Mn
8 Gores Holdings X 385.06 Mn 384.87 Mn - 1.88 Mn
9 Agriculture & Natural Solutions Acquisition 377.29 Mn 377.04 Mn - -
10 Drugs Made In America Acquisition 215.82 Mn 215.82 Mn - 1.73 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 212,958.00
Sep 30, 2025 2.18 Mn
Jun 30, 2025 2.29 Mn
Mar 31, 2025 1.25 Mn